Last reviewed · How we verify
NuTRIflex Lipid peri
NuTRIflex Lipid peri is a parenteral nutrition emulsion that provides essential lipids, amino acids, and other nutrients for perioperative nutritional support in patients unable to eat normally.
NuTRIflex Lipid peri is a parenteral nutrition emulsion that provides essential lipids, amino acids, and other nutrients for perioperative nutritional support in patients unable to eat normally. Used for Perioperative nutritional support in patients unable to receive oral or enteral nutrition.
At a glance
| Generic name | NuTRIflex Lipid peri |
|---|---|
| Sponsor | B. Braun Melsungen AG |
| Drug class | Parenteral nutrition formulation |
| Modality | Small molecule |
| Therapeutic area | Nutritional support / Critical care |
| Phase | Phase 3 |
Mechanism of action
This is a ready-to-use, all-in-one parenteral nutrition formulation designed for perioperative use. It combines lipid emulsion, amino acids, glucose, electrolytes, and trace elements to meet nutritional requirements during the perioperative period when oral or enteral nutrition is not feasible. The lipid component provides essential fatty acids and concentrated calories.
Approved indications
- Perioperative nutritional support in patients unable to receive oral or enteral nutrition
Common side effects
- Infusion site reactions
- Hyperglycemia
- Electrolyte imbalances
- Lipemia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NuTRIflex Lipid peri CI brief — competitive landscape report
- NuTRIflex Lipid peri updates RSS · CI watch RSS
- B. Braun Melsungen AG portfolio CI